Abstract: Methods for the isolation and identification of a toxicant in a sample are disclosed. Luminescent biological agents (i.e., bacteria) having sensitivity to a toxicant or an isolatable component in a sample are used to provide visually discernable zones of luminescent inhibition in the presence of a toxicant (or) in the presence of an isolatable sample component as separated by paper or thin layer chromatography. Kits for use in conjunction with the identification of a toxicant in a sample are also described, which include a luminescent biological reagent as the visualizing agent. Particular examples of luminescent bacterial agents useful in the practice of the present invention include Photobacterium leoganthi, Photobacterium phosphoreum, Vibrio fischeri, Vibrio harveyi a luminescent fungi, a luminescent fish extract, a luminescent dinoflagellate and fluorescent microorganisms, such as Cypridina.
Abstract: This invention relates to the field of human medicine, more specifically to dermatology, and in particular to a composition developed for the stimulation of the synthesis of the melanic pigment of the skin, therefore useful for the treatment of vitiligo. The technical goal of this invention is to provide a composition of natural origin useful in the treatment of vitiligo that has no toxic effects and no relapse. The composition obtained stimulates the synthesis of the melanic pigment of the skin and the reproduction of melanocytes, as demonstrated through pharmacological tests to which the composition was subjected, causing no serious secondary reactions at all, as demonstrated in the toxicological, teratological and clinical tests performed. The resulting product can easily be obtained and applied, repigmentation begins rapidly after initiating the treatment, and the effect is irreversible.
Abstract: A composition is obtained from Banyan tree bark that has insulin antisecretory and cytotoxic properties. The composition can be useful in treating conditions characterized by hyperinsulinism including insulinoma and infant hyperinsulinism.
Abstract: A powerful formulation for preventing and treating macular degeneration, cataracts, glaucoma and other eye diseases, and contains over thirty naturally effective vitamins, minerals, phytonutrients and amino acids, which have all been found to demonstrate a powerful protective effect on the health of the eye.
Abstract: A bath for generating microstructures which is required in numerous fields of application of the microsystem technique and in microstructuring offers a less expensive alternative to known conventional approaches and disposal of the used bath may be carried out in a manner more environmentally friendly manner than in the previous methods for manufacture of microstructures. The bath includes at least one biogenic agent (in particular, an enzyme) which acts upon a preselectable thin layer.
Type:
Grant
Filed:
February 5, 1999
Date of Patent:
November 11, 2003
Assignee:
Clondiag Chip Technologies GmbH
Inventors:
Eugen Ermantraut, Johann Michael Köhler, Torsten Schulz, Klaus Wohlfart
Abstract: A laxative preparation obtained by the direct bioactive chloroform or methanolic extraction of rhizomes and/or roots of Picrorrhiza Kurroa and its method for manufacture. The laxative preparation can be used for treatment of human beings for relieving constipation using the same.
Abstract: The invention is related to a pharmaceutical composition with its main effects against Type I Allergy and the process thereof. The composition mainly comprises the following raw materials by weight ratio: 30˜60 parts of Fructus Jujubae, 12˜55 parts of Radix Astragali, 8˜15 parts of Radix glycyrrhizae, 6˜12 parts of Ramulus cinnamomi, 6˜12 parts of Ginger and 4˜8 parts of Green tea.
Abstract: A composition comprising (a) soy protein, (b) a phytoestrogen compound, and (c) dietary fibers. The soy protein (a) is present in an amount of at least 45 weight percent of the total protein content of the composition, said total protein content providing at least 15 percent of the total energy content of the composition. The phytoestrogen compound (b) is preferably a naturally occuring isoflavone and is present in an amount of more than 0.10 weight percent of the soy protein, and the dietary fibers (c) are preferably soybean fibers and are present in an amount of more than 4 weight percent of the total weight of the nutritional composition on a dry basis. The composition is useful in lowering serum cholesterol and LDL-cholesterol and serum triglyceride levels and for increasing the HDL/LDL-cholesterol ratio in serum of a subject suffering from arteriosclerosis and related cardiovascular diseases.
Abstract: The invention relates to raspberry seed oil derivatives prepared by the reaction of dimethicone copolyol and cold pressed raspberry seed oil. The choice of cold pressed raspberry seed oil as a raw material in the preparation of the compounds is critical, since it has been found that the cold pressed raspberry seed oil contains antioxidants, antimicrobial compounds and which when reacted with a water soluble or water dispersible silicone result in products that deliver said actives to the skin and hair, resulting in protection of the skin and hair from environmental factors such as acid rain, ozone attack and UV degradation.
Type:
Grant
Filed:
November 12, 2002
Date of Patent:
October 7, 2003
Assignee:
Zenitech LLC
Inventors:
Kenneth Klein, Irwin Paleksky, Anthony J. O'Lenick, Jr.
Abstract: The present invention relates to a new herbal synergistic formulation, comprising essential oil of medicinal plant Foeniculum vulgare and other plants and said formulation useful as insecticide against mosquito larvae; in addition, the formulation of the present invention has toxic action against larval stages of malarial vector, Anopheles stephensi due to the property attributed by the synergistic combination of essential oil of plant genus Foeniculum vulgare and other essential oils derived from medicinal plants.
Type:
Grant
Filed:
March 21, 2002
Date of Patent:
September 23, 2003
Assignee:
Council of Scientific and Industrial Research
Abstract: A soya extract having a content of glucoside isoflavones of at least 13% by weight and a content of 0.6 to 1.5 parts by weight of group B soya saponins per 1 part by weight of glucoside isoflavones. Also, pharmaceutical compositions containing this extract and methods of administering the extract to treat conditions such as pre- or post-menopausal symptoms, cancer, such as breast or prostrate cancer, or alcoholism. The extracts are made by a process which includes the steps of treating ripe whole soya beans or oil-free soya flour with an aliphatic alcohol to obtain a first extract; concentrating the first extract to form a concentrated first extract; purifying the concentrated first extract by treatment with at least one aliphatic hydrocarbon; and extracting active components from the purified concentrated first extract with a water-immiscible aliphatic alcohol to obtain a second extract. Preferably, the final extract is concentrated and dried to form the desired soya extract.
Abstract: A bindweed and buckwheat extract is used to inhibit the growth of tumor cells, inhibit the growth of blood vessels, and enhance immune function. The bindweed and buckwheat extract requires minimal purification and produces a low toxicity anti-tumor and immuno-stimulating extract.
Type:
Grant
Filed:
January 25, 2002
Date of Patent:
July 29, 2003
Assignee:
The Center for the Improvement of Human Functioning, Int.,
Inc.
Inventors:
Xiaolong Meng, Hugh D. Riordan, Neil H. Riordan
Abstract: Antifungal compositions having enhanced antifungal activity comprising an antifungal agent and a food additive are described. Also described are a method for inhibiting fungal growth using the compositions with enhanced activity and the use of a food additive to enhance the antifungal properties of an antifungal agent.
Type:
Grant
Filed:
December 21, 1999
Date of Patent:
July 29, 2003
Assignee:
Syngenta Limited
Inventors:
Andrew James Greenland, Angel Manuel Fuentes Mateos
Abstract: A bindweed and buckwheat extract is used to inhibit the growth of tumor cells, inhibit the growth of blood vessels, and enhance immune function. The bindweed and buckwheat extract requires minimal purification and produces a low toxicity anti-tumor and immunostimulating extract.
Type:
Grant
Filed:
January 25, 2002
Date of Patent:
July 22, 2003
Assignee:
The Center for the Improvement of Human Functioning, Int.,
Inc.
Inventors:
Xiaolong Meng, Hugh D. Riordan, Neil H. Riordan
Abstract: A composition for treating hypertension and lowering cholesterol is provided which contains the mixed extract of Panax notoginseng and Salvia miltiorrhiza as an active ingredient thus lowering and maintaining blood pressure substantially constant. Also provided is a method for preparing composition containing the mixed extract of Panax notoginseng and Salvia miltiorrhiza as an active ingredient.
Abstract: In order to provide a xanthine oxidase inhibitor having as an effective component an extract from highly safe plants, ten kinds of plant materials were compared for the xanthine oxidase inhibition activity, and in consequence Lagerstroemia speciosa (banaba) was found to have the strongest activity. In addition, it was found that the xanthine oxidase inhibition activity was present in an “crude extract” obtained by extracting banaba with hot water or the like, “resin adsorbed components” obtained by adsorbing the crude extract on a styrene-divinyl benzene synthetic resin or the like, and “organic solvent soluble components” obtained by the partition of the resin adsorbed component between water and an organic solvent.
Abstract: An herbal composition comprised of extracts from the following herbs: Garlic (Allium Sativum), Onion (Allium Cepa), Cat Claw (Macfadyena Unguis-cati), Rat Root (Chicocca Alba), Pear Leaf (Persea Americana), Billyweb Bark (Sweetia Panamensis), Strongback (Desmodium Abscendens), Aloe (Aloe Barbadensis), Life Leaf (Bryophyllum Pinnatum), Sarsaparilla (Smilax Officinalis), Bamboo (Aralia Mubicaulis), Geritout (Pluchea Symphytofolia), Hibiscus (Hibiscus Rosa-sinensis), Balsam (Myroxylon Balsamum). The composition acts as a tonic to improve respiration, aid in the elimination of toxins and improves overall vitality.
Abstract: A therapeutic oil composition is provided that is useful for topical application to painful areas of the human body. The therapeutic oil composition is created by mixing essentials oils of Eugenia caryophyllata, Myroxylon balsamum var. pereirae, Eucalyptus globulus var. globulus, Lavandula augustifolia, Mentha piperita, and Mentha spicata. The volume of each constituent added can be modified according to the desired treatment. The mixture is then aged by storing it in the dark at a temperature of between 50° F. to 60° F. for at least thirty-six hours. The composition may be applied topically in 100% strength, or mixed with an oil-based carrier, and allowed to enter through the skin and into the tissue to relieve complaints of physical pain, including muscular aches and pains, arthritis and respiratory distress.
Abstract: A method for producing a fermentative product by utilizing a microorganism, the method comprising culturing the microorganism in a medium to produce and accumulate the fermentative product in the medium, and collecting the fermentative product, wherein the microorganism expresses a heat shock protein derived from a hyperthermophilic archaeon strain KOD-1 in a cell of the microorganism by introduction of a gene coding for the heat shock protein.